CV Lattes
ORCID
Google Scholar Citations
Universidade Estadual de Campinas (UNICAMP). Instituto de Biologia (IB) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Currently a fourth-year medical student at the State University of Campinas (Unicamp). Since 2023, I have been conducting Scientific Research as a FAPESP undergraduate fellow in the Laboratory of Neuroproteomics, under the supervision of Prof. Dr. Daniel Martins-De-Souza. Since 2021, I have also been interning in general psychiatry, as well as child and adolescent psychiatry, at the gender outpatient clinic of the Unicamp Clinical Hospital, where I participate in research activities related to the physical health of transgender individuals. I have experience in academic and outreach activities, having served as a teaching assistant (PAD) for an undergraduate course, and participated in outreach activities within the context of medical ethics. My experience also includes human cell culture, mass spectrometry-based proteomics and metabolomics, clinical psychiatry, among other topics. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Schizophrenia is characterized by the onset of positive (delusions and hallucinations), negative (such as anhedonia), and cognitive symptoms and affects nearly 200 million people worldwide. The atypical antipsychotics used to treat this disease work by blocking dopamine D2 receptors and antagonizing 5-HT2A receptors. Nearly 26% of patients with a first episode of psychosis present with de…
Schizophrenia, which affects almost 200 million people, is characterized by positive symptoms, such as hallucinations. It is understood that these patients exhibit exacerbations on subcortical dopamine circuits and hypoactivation on cortical. The treatment consists of the administration of antipsychotics, which antagonize D2 receptors but, if atypical, also block the 5-HT2A receptors. Alt…
| 2 / 2 | Completed scholarships in Brazil |
| Associated processes | |